The MFDS classifies medical devices in South Korea based on risk levels into three categories: Class I (low risk), Class II (moderate risk), and Class III (high risk). This classification determines the regulatory requirements for approval, with higher-risk devices undergoing more rigorous evaluation and clinical testing to ensure safety and efficacy before market entry.